Concanavalin A (ConA)-induced hepatitis is an experimental murine model mirroring the pathology of human autoimmune hepatitis.To investigate the effects of intrasplenically transplanted fetal hepatocytes (BNL.CL2) transfected with recombinant adenovirus vector expressing the IL-18 binding protein (IL-18BP) and IL-4 fusion protein on ConA-induced hepatitis in mice. sacrificed 18 hours later. Liver injury was assessed by serum transaminase and liver histology. TNF-α, IL-18, IL-4, IL-10, IL-12p70 and monocyte-chemoattracting protein (MCP)-1 levels in serum and liver homogenates were detected by ELISA. Signaling molecules in liver homogenates were analyzed by Western blotting..CL2 were lower and IL-4 and IL-10 levels were higher than control gr...
<p>Murine hepatitis was induced by an intravenous injection of Con A at a dose of 15 mg/kg. BE (100 ...
Objective To explore the prevention of IL-18 or anti-IL-18-mAb to the immune liver fibrosis model in...
<p>(A) Liver pathogenesis in Rag−/− and H2M−/− Rag−/− recipients after H2M−/− T cell transfer. (B) A...
Concanavalin A (ConA)-induced hepatitis is an experimental murine model mirroring the pathology of h...
Concanavalin A (ConA)-induced hepatitis is an experimental murine model mirroring the pathology of h...
<p>Ten days after intrasplenic transplantation of Ad-IL-18BP/IL-4-BNL.CL2 or control cells, mice fro...
<p>(<b>A</b>) Mouse peripheral blood was harvested 18 hours after ConA injection and ALT and AST act...
Concanavalin A (ConA)-induced hepatitis is a cell-mediated immunoinflammatory condition similar to h...
The liver has the ability to prime immune responses against neo antigens provided upon infections. H...
Experimental T-cell-mediated hepatitis induced by concanavalin A (Con A) involves the production of ...
Background/Aims: Autoimmune hepatitis (AIH) is a chronic necroinflammatory disease of the liver whos...
Inflammation of the normally tolerant liver microenvironment precedes the development of chronic liv...
The liver has the ability to prime immune responses against neo antigens provided upon infections. H...
BACKGROUND: Interleukin 18 (IL-18) is a cytokine with pleiotropic activity that augments T helper 1 ...
<p>(A) Eight million OT-I T-cells were transferred intravenously into TF-OVA mice (+ Hepatitis), or ...
<p>Murine hepatitis was induced by an intravenous injection of Con A at a dose of 15 mg/kg. BE (100 ...
Objective To explore the prevention of IL-18 or anti-IL-18-mAb to the immune liver fibrosis model in...
<p>(A) Liver pathogenesis in Rag−/− and H2M−/− Rag−/− recipients after H2M−/− T cell transfer. (B) A...
Concanavalin A (ConA)-induced hepatitis is an experimental murine model mirroring the pathology of h...
Concanavalin A (ConA)-induced hepatitis is an experimental murine model mirroring the pathology of h...
<p>Ten days after intrasplenic transplantation of Ad-IL-18BP/IL-4-BNL.CL2 or control cells, mice fro...
<p>(<b>A</b>) Mouse peripheral blood was harvested 18 hours after ConA injection and ALT and AST act...
Concanavalin A (ConA)-induced hepatitis is a cell-mediated immunoinflammatory condition similar to h...
The liver has the ability to prime immune responses against neo antigens provided upon infections. H...
Experimental T-cell-mediated hepatitis induced by concanavalin A (Con A) involves the production of ...
Background/Aims: Autoimmune hepatitis (AIH) is a chronic necroinflammatory disease of the liver whos...
Inflammation of the normally tolerant liver microenvironment precedes the development of chronic liv...
The liver has the ability to prime immune responses against neo antigens provided upon infections. H...
BACKGROUND: Interleukin 18 (IL-18) is a cytokine with pleiotropic activity that augments T helper 1 ...
<p>(A) Eight million OT-I T-cells were transferred intravenously into TF-OVA mice (+ Hepatitis), or ...
<p>Murine hepatitis was induced by an intravenous injection of Con A at a dose of 15 mg/kg. BE (100 ...
Objective To explore the prevention of IL-18 or anti-IL-18-mAb to the immune liver fibrosis model in...
<p>(A) Liver pathogenesis in Rag−/− and H2M−/− Rag−/− recipients after H2M−/− T cell transfer. (B) A...